The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Doripenem is an ultra-broad-spectrum injectable antibiotic. It is a beta-lactam and belongs to the subgroup of carbapenems. It was launched by Shionogi Co. of Japan under the brand name Finibax in 2005 and is being marketed outside Japan by Johnson & Johnson. It is particularly active against Pseudomonas aeruginosa. The usual form is doripenem monohydrate.
The global Doripenem market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Doripenem is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Doripenem is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Doripenem in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Doripenem include Janssen, Shionogi and Apotex, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Doripenem, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Doripenem.
Report Scope
The Doripenem market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Doripenem market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Doripenem companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Janssen
Shionogi
Apotex
Segment by Type
500 mg single-use vial
250 mg single-use vial
Segment by Application
Hospital
Drug store
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Doripenem companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Doripenem is an ultra-broad-spectrum injectable antibiotic. It is a beta-lactam and belongs to the subgroup of carbapenems. It was launched by Shionogi Co. of Japan under the brand name Finibax in 2005 and is being marketed outside Japan by Johnson & Johnson. It is particularly active against Pseudomonas aeruginosa. The usual form is doripenem monohydrate.
The global Doripenem market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Doripenem is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Doripenem is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Doripenem in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Doripenem include Janssen, Shionogi and Apotex, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Doripenem, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Doripenem.
Report Scope
The Doripenem market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Doripenem market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Doripenem companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Janssen
Shionogi
Apotex
Segment by Type
500 mg single-use vial
250 mg single-use vial
Segment by Application
Hospital
Drug store
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Doripenem companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Doripenem Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 500 mg single-use vial
1.2.3 250 mg single-use vial
1.3 Market by Application
1.3.1 Global Doripenem Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Drug store
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Doripenem Market Perspective (2019-2030)
2.2 Doripenem Growth Trends by Region
2.2.1 Global Doripenem Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Doripenem Historic Market Size by Region (2019-2024)
2.2.3 Doripenem Forecasted Market Size by Region (2025-2030)
2.3 Doripenem Market Dynamics
2.3.1 Doripenem Industry Trends
2.3.2 Doripenem Market Drivers
2.3.3 Doripenem Market Challenges
2.3.4 Doripenem Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Doripenem Players by Revenue
3.1.1 Global Top Doripenem Players by Revenue (2019-2024)
3.1.2 Global Doripenem Revenue Market Share by Players (2019-2024)
3.2 Global Doripenem Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Doripenem Revenue
3.4 Global Doripenem Market Concentration Ratio
3.4.1 Global Doripenem Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Doripenem Revenue in 2023
3.5 Doripenem Key Players Head office and Area Served
3.6 Key Players Doripenem Product Solution and Service
3.7 Date of Enter into Doripenem Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Doripenem Breakdown Data by Type
4.1 Global Doripenem Historic Market Size by Type (2019-2024)
4.2 Global Doripenem Forecasted Market Size by Type (2025-2030)
5 Doripenem Breakdown Data by Application
5.1 Global Doripenem Historic Market Size by Application (2019-2024)
5.2 Global Doripenem Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Doripenem Market Size (2019-2030)
6.2 North America Doripenem Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Doripenem Market Size by Country (2019-2024)
6.4 North America Doripenem Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Doripenem Market Size (2019-2030)
7.2 Europe Doripenem Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Doripenem Market Size by Country (2019-2024)
7.4 Europe Doripenem Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Doripenem Market Size (2019-2030)
8.2 Asia-Pacific Doripenem Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Doripenem Market Size by Region (2019-2024)
8.4 Asia-Pacific Doripenem Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Doripenem Market Size (2019-2030)
9.2 Latin America Doripenem Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Doripenem Market Size by Country (2019-2024)
9.4 Latin America Doripenem Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Doripenem Market Size (2019-2030)
10.2 Middle East & Africa Doripenem Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Doripenem Market Size by Country (2019-2024)
10.4 Middle East & Africa Doripenem Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Janssen
11.1.1 Janssen Company Detail
11.1.2 Janssen Business Overview
11.1.3 Janssen Doripenem Introduction
11.1.4 Janssen Revenue in Doripenem Business (2019-2024)
11.1.5 Janssen Recent Development
11.2 Shionogi
11.2.1 Shionogi Company Detail
11.2.2 Shionogi Business Overview
11.2.3 Shionogi Doripenem Introduction
11.2.4 Shionogi Revenue in Doripenem Business (2019-2024)
11.2.5 Shionogi Recent Development
11.3 Apotex
11.3.1 Apotex Company Detail
11.3.2 Apotex Business Overview
11.3.3 Apotex Doripenem Introduction
11.3.4 Apotex Revenue in Doripenem Business (2019-2024)
11.3.5 Apotex Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Doripenem Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of 500 mg single-use vial
Table 3. Key Players of 250 mg single-use vial
Table 4. Global Doripenem Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Doripenem Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Doripenem Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Doripenem Market Share by Region (2019-2024)
Table 8. Global Doripenem Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Doripenem Market Share by Region (2025-2030)
Table 10. Doripenem Market Trends
Table 11. Doripenem Market Drivers
Table 12. Doripenem Market Challenges
Table 13. Doripenem Market Restraints
Table 14. Global Doripenem Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Doripenem Market Share by Players (2019-2024)
Table 16. Global Top Doripenem Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Doripenem as of 2023)
Table 17. Ranking of Global Top Doripenem Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Doripenem Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Doripenem Product Solution and Service
Table 21. Date of Enter into Doripenem Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Doripenem Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Doripenem Revenue Market Share by Type (2019-2024)
Table 25. Global Doripenem Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Doripenem Revenue Market Share by Type (2025-2030)
Table 27. Global Doripenem Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Doripenem Revenue Market Share by Application (2019-2024)
Table 29. Global Doripenem Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Doripenem Revenue Market Share by Application (2025-2030)
Table 31. North America Doripenem Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Doripenem Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Doripenem Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Doripenem Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Doripenem Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Doripenem Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Doripenem Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Doripenem Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Doripenem Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Doripenem Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Doripenem Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Doripenem Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Doripenem Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Doripenem Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Doripenem Market Size by Country (2025-2030) & (US$ Million)
Table 46. Janssen Company Detail
Table 47. Janssen Business Overview
Table 48. Janssen Doripenem Product
Table 49. Janssen Revenue in Doripenem Business (2019-2024) & (US$ Million)
Table 50. Janssen Recent Development
Table 51. Shionogi Company Detail
Table 52. Shionogi Business Overview
Table 53. Shionogi Doripenem Product
Table 54. Shionogi Revenue in Doripenem Business (2019-2024) & (US$ Million)
Table 55. Shionogi Recent Development
Table 56. Apotex Company Detail
Table 57. Apotex Business Overview
Table 58. Apotex Doripenem Product
Table 59. Apotex Revenue in Doripenem Business (2019-2024) & (US$ Million)
Table 60. Apotex Recent Development
Table 61. Research Programs/Design for This Report
Table 62. Key Data Information from Secondary Sources
Table 63. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Doripenem Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Doripenem Market Share by Type: 2023 VS 2030
Figure 3. 500 mg single-use vial Features
Figure 4. 250 mg single-use vial Features
Figure 5. Global Doripenem Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Doripenem Market Share by Application: 2023 VS 2030
Figure 7. Hospital Case Studies
Figure 8. Drug store Case Studies
Figure 9. Doripenem Report Years Considered
Figure 10. Global Doripenem Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global Doripenem Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Doripenem Market Share by Region: 2023 VS 2030
Figure 13. Global Doripenem Market Share by Players in 2023
Figure 14. Global Top Doripenem Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Doripenem as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by Doripenem Revenue in 2023
Figure 16. North America Doripenem Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America Doripenem Market Share by Country (2019-2030)
Figure 18. United States Doripenem Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada Doripenem Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe Doripenem Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Doripenem Market Share by Country (2019-2030)
Figure 22. Germany Doripenem Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France Doripenem Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. Doripenem Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy Doripenem Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia Doripenem Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries Doripenem Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific Doripenem Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Doripenem Market Share by Region (2019-2030)
Figure 30. China Doripenem Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan Doripenem Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea Doripenem Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia Doripenem Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India Doripenem Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia Doripenem Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America Doripenem Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Doripenem Market Share by Country (2019-2030)
Figure 38. Mexico Doripenem Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil Doripenem Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Doripenem Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Doripenem Market Share by Country (2019-2030)
Figure 42. Turkey Doripenem Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia Doripenem Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Janssen Revenue Growth Rate in Doripenem Business (2019-2024)
Figure 45. Shionogi Revenue Growth Rate in Doripenem Business (2019-2024)
Figure 46. Apotex Revenue Growth Rate in Doripenem Business (2019-2024)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
